Novo Nordisk has quietly become one of the most dominant and profitable companies in global healthcare. Founded a century ago through a medical breakthrough and a love story, it now leads the charge in treating diabetes, obesity, and chronic diseases. If you've heard of Ozempic or Wegovy, you already know part of the story. But the full picture is even more compelling.

Trade fuels prosperity. But today, global markets are on edge—not because of tariffs alone, but because no one knows what comes next.

When tariffs hit the headlines, they often sound like a bold move to protect jobs, revive industries, and put “America First.” But what if the real result is higher prices, lost jobs, and a slower economy?

Here’s the truth: tariffs are taxes. And like most taxes, someone ends up footing the bill – usually you.

Trade wars don’t just raise prices — they kill confidence

Core Natural Resources Inc. (CNR) is a name that’s quietly making waves in the investing world. With a $4.04 billion market cap and deep roots in coal mining dating back to 1864, this company just underwent a major transformation. After a merger of equals between CONSOL and Arch Resources in early 2025, the new entity has emerged with serious momentum. Legendary investor Mohnish Pabrai has taken notice—allocating a staggering 25% of his U.S. portfolio to this single coal stock. That’s not just a bet. It’s a conviction.